ASCO in Action

ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.

To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.

Tune in to the ASCO in Action podcast series for analysis and commentary on cancer policy and practice issues. The podcast is available through iTunes or Google Play.

March 4, 2020

March 4 is International HPV Awareness Day, which aims to promote education about the human papillomavirus (HPV), raise awareness about prevention methods, and encourage governments and individuals to take advantage of the HPV vaccine and screening for cancer—goals that ASCO supports.

March 3, 2020

The Association for Clinical Oncology (ASCO) recently joined more than a dozen other health groups in sending a letter to leaders of the Senate Committee on Health, Education, Labor, and Pensions (HELP) to convey their support of S.2723—The Mitigating Emergency Drug Shortages (MEDS) Act—which would help reduce drug shortages by addressing vulnerabilities in the drug supply chain. The letter urges the committee to quickly advance this important piece of legislation.  

March 3, 2020

In a letter to the Centers for Medicare & Medicaid Services (CMS), the Association for Clinical Oncology (ASCO) expressed concerns regarding two provisions in the 2021 Affordable Care Act (ACA) Notice of Benefit and Payment Parameters proposed rule. This proposal, if implemented, would update the regulatory and financial standards applied to ACA Exchanges.

March 3, 2020

In a letter to Representatives Terri Sewell (AL), Adrian Smith (NE), Tony Cárdenas (CA), and John Shimkus (IL), the Association for Clinical Oncology (ASCO) conveyed its support for legislation the lawmakers introduced in the U.S. House of Representatives. The bill, H.R.

March 3, 2020

Starting January 1, 2021, there will be significant changes to the office and outpatient Evaluation and Management (E&M) services Current Procedural Terminology (CPT ®) codes (99202-99215), for both new and established patients. Practices, physicians, and staff must prepare in advance for these changes to ensure a successful transition next year and avoid any disruption in reimbursement.

March 2, 2020

From the American Society of Clinical Oncology in cooperation with the Food and Drug Administration (FDA) and as a service to our members, ASCO will periodically distribute information about newly approved therapies for cancer patients. This helps FDA inform oncologists and professionals in oncology-related fields about recent approvals in a timely manner. Included in the email from the FDA will be a link to the product label, which will provide the relevant clinical information on the indication, contraindications, dosing, and safety.

February 26, 2020

From the American Society of Clinical Oncology in cooperation with the Food and Drug Administration (FDA) and as a service to our members, ASCO will periodically distribute information about newly approved therapies for cancer patients. This helps FDA inform oncologists and professionals in oncology-related fields about recent approvals in a timely manner. Included in the email from the FDA will be a link to the product label, which will provide the relevant clinical information on the indication, contraindications, dosing, and safety.

February 19, 2020

The 2020 general election is right around the corner, and all 435 members of the United States (U.S.) House of Representatives—and 35 U.S. Senators—are up for re-election. This means that Members of Congress will be spending more time in their home district or state this year and are more available for in-district meetings with constituents as a result. You could even invite your lawmakers to visit your practice.  

February 19, 2020

This Cancer Prevention Month, the American Society of Clinical Oncology (ASCO) is supporting the American Institute of Cancer Research’s (AIRC) efforts to spread awareness about ways to help prevent a cancer diagnosis. 

February 19, 2020

The American Society of Clinical Oncology (ASCO) today released a position statement on state drug repository programs, outlining ASCO’s support for drug repository programs solely for oral medications provided they are maintained within a closed system. The Society also makes recommendations to help ensure that these programs are implemented appropriately, with sufficient patient protections in place. 

February 18, 2020

The Association for Clinical Oncology (ASCO) is calling on Members of Congress to continue their support for federally funded research by providing $44.7 billion for the National Institutes of Health (NIH), including $6.9 billion for the National Cancer Institute (NCI) in Fiscal Year (FY) 2021. The $3 billion funding increase for NIH will help the agency continue to regain some of the ground it lost after years of effectively flat budgets so the U.S. biomedical research enterprise can continue its important work in support of new advances and cures for patients.

February 18, 2020
On February 11, members of the Association for Clinical Oncology’s (ASCO) Government Relations Committee met with several federal agencies and stakeholder groups to discuss top cancer policy priorities.

The meetings focused on drug pricing, access to clinical trials, Medicaid expansion and block grants, accelerated drug approval pathways, and other issues affecting people with cancer and their oncology care teams.

February 18, 2020

On February 18, 106 organizations representing patients, providers, medical researchers, survivors, and families joined together to urge Congress to include the bipartisan CLINICAL TREATMENT Act (H.R. 913) in the upcoming ‘must pass’ healthcare extenders package, which is expected to pass this spring. 

February 7, 2020

Thirty-three practices in three countries have committed to providing high quality care by receiving the Quality Oncology Practice Initiative (QOPI®) Certification in the fourth quarter of 2019. The Association for Clinical Oncology (Association) applauds the work of these practices to ensure a better and healthier future.

Pages